1. Home
  2. DHT vs IRON Comparison

DHT vs IRON Comparison

Compare DHT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHT Holdings Inc.

DHT

DHT Holdings Inc.

HOLD

Current Price

$21.84

Market Cap

2.9B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$65.44

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHT
IRON
Founded
2005
2017
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
DHT
IRON
Price
$21.84
$65.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$19.33
★ $103.18
AVG Volume (30 Days)
★ 3.7M
473.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
★ 5.36%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.85
N/A
Revenue Next Year
N/A
$283.52
P/E Ratio
$12.73
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.83
$40.00
52 Week High
$23.56
$99.50

Technical Indicators

Market Signals
Indicator
DHT
IRON
Relative Strength Index (RSI) 58.44 24.60
Support Level $16.65 $58.30
Resistance Level $23.56 $72.68
Average True Range (ATR) 0.78 2.86
MACD -0.12 -0.66
Stochastic Oscillator 44.01 5.34

Price Performance

Historical Comparison
DHT
IRON

About DHT DHT Holdings Inc.

DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: